Search

everythinglearnresearchcommunity

for

Search:↓

A simple method using the wash test and dermatoscopy can help differentiate between two hair loss conditions, androgenetic alopecia and chronic telogen effluvium.

Low levels of iron and vitamin D might be linked to chronic hair loss in women.

Understanding hair follicle biology and stem cell control could lead to new hair loss treatments.

Women's hair generally gets thinner and less dense starting in their mid-thirties, with hair loss becoming more common as they age due to both genetics and environment.

Higher lead and cadmium, and lower zinc and iron levels in the blood might be linked to chronic hair loss in women.

The study concluded that low iron and vitamin D levels in women might play a role in chronic hair loss, despite no significant difference between those with and without hair loss.

Some people with chronic hair loss may have thyroid autoimmunity.

Emotional stress can trigger intermittent hair loss in chronic telogen effluvium, which may not improve with treatment if stress continues.

The guide helps dermatologists diagnose and treat different types of hair loss.

People with chronic hair loss often have lower Vitamin B12 levels.

Hormonal imbalances contribute to female hair loss, and trichoscopy is a useful diagnostic tool.

Low iron, low thyroid function, and stress are linked to excessive hair shedding in women.

TrichoScan often makes mistakes and needs improvement for correct hair growth analysis.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

Unani medicine effectively reduced hair loss in a 24-year-old woman without side effects.

Stress can cause temporary hair loss, which usually gets better after the stress is gone.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Chemotherapy can cause rapid, extensive hair loss, with patterns varying between individuals.

Vitamin D3 deficiency is common in Pakistanis with diffuse hair fall, and early treatment is advised.

Biotin deficiency is not a major cause of hair loss in women, so biotin supplements are not likely to be an effective hair loss treatment.

Certain gene variations in the Vitamin D receptor may increase the risk of chronic hair loss.

Weight loss can cause temporary hair loss, especially in women and older adults.

Hair loss can happen after severe H1N1 flu but usually grows back in 4 months.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

About 12% of children in Kota, Rajasthan, experience hair loss, mainly due to fungal infections, with early treatment advised to prevent worsening.

Low serum ferritin is linked to hair loss in women.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

Different types of hair loss have unique features under a microscope, but a doctor's exam is important for accurate diagnosis.